Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Immobilized Human GITR Ligand, Fc Tag at 10 μg/mL (100 μL/well) can bind Biotinylated Human GITR, His,Avi tag™ (Cat. No. GIR-H82E1) with a linear range of 0.039-0.625 μg/mL (QC tested).
The purity of Biotinylated Human GITR Protein, His,Avitag (Cat. No. GIR-H82E1) is more than 95% and the molecular weight of this protein is around 20-30 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
BMS-986156 | BMS-986156 | Phase 2 Clinical | Bristol-Myers Squibb Company | Solid tumours; Liver Neoplasms; Thoracic Neoplasms; Neoplasms; Lung Neoplasms | Details |
Ragifilimab | INCAGN-1876; INCAGN-01876; AGEN-1876; CM-701 | Phase 2 Clinical | Agenus Inc, Ludwig Institute For Cancer Research | Neoplasms; Neoplasm Metastasis | Details |
Anti-GITR antibody (BMS) | Phase 1 Clinical | Bristol-Myers Squibb Company | Neoplasms | Details | |
LY-3844583 | LY-3844583; LY3844583 | Phase 1 Clinical | Eli Lilly And Company | Dermatitis, Atopic | Details |
REGN-6569 | REGN-6569; REGN6569 | Phase 1 Clinical | Squamous Cell Carcinoma of Head and Neck | Details | |
GWN-323 | GWN-323 | Phase 1 Clinical | Novartis Pharma Ag | Solid tumours; Lymphoma | Details |
MK-4166 | MK-4166 | Phase 1 Clinical | Merck & Co Inc | Solid tumours | Details |
BMS-986156 | BMS-986156 | Phase 2 Clinical | Bristol-Myers Squibb Company | Solid tumours; Liver Neoplasms; Thoracic Neoplasms; Neoplasms; Lung Neoplasms | Details |
Ragifilimab | INCAGN-1876; INCAGN-01876; AGEN-1876; CM-701 | Phase 2 Clinical | Agenus Inc, Ludwig Institute For Cancer Research | Neoplasms; Neoplasm Metastasis | Details |
Anti-GITR antibody (BMS) | Phase 1 Clinical | Bristol-Myers Squibb Company | Neoplasms | Details | |
LY-3844583 | LY-3844583; LY3844583 | Phase 1 Clinical | Eli Lilly And Company | Dermatitis, Atopic | Details |
REGN-6569 | REGN-6569; REGN6569 | Phase 1 Clinical | Squamous Cell Carcinoma of Head and Neck | Details | |
GWN-323 | GWN-323 | Phase 1 Clinical | Novartis Pharma Ag | Solid tumours; Lymphoma | Details |
MK-4166 | MK-4166 | Phase 1 Clinical | Merck & Co Inc | Solid tumours | Details |
This web search service is supported by Google Inc.